Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Direct Meds is a telehealth platform offering compounded semaglutide and tirzepatide the active ingredients used in several FDA-approved GLP-1 medications for diabetes and chronic weight management through an online consultation and home delivery model
Beyond gastrointestinal symptoms, other adverse effects observed in trials include injection site reactions (such as redness, bruising, or mild swelling), fatigue, dizziness, and small mean increases in heart rate
G., Grubaugh, N
Comparison to Existing Protocols Compared to semaglutide, which begins at 0.25 mg weekly and gradually titrates to 2.4 mg, Retatrutides dose range is significantly higher (up to 12 mg)
US$ 20.32
![Updated] GLP-1-RAs Swoop to Chinese Market, Eyeing Diabetes Treatment & Weight Control Needs](https://resource.chemlinked.com.cn/baipharm/articles/chinas-glp-1-ra-market-is-fueled-by-glycemic-control-weight-loss-needs.jpg)
US$ 24.69
US$ 22.22
